Literature DB >> 21540133

Targeted mass spectrometry approaches for protein biomarker verification.

Zhaojing Meng1, Timothy D Veenstra.   

Abstract

The search for protein biomarkers has been a highly pursued topic in the proteomics community in the last decade. This relentless search is due to the constant need for validated biomarkers that could facilitate disease risk stratification, disease diagnosis, prognosis, monitoring as well as drug development, which ultimately would improve our quality of life. The recent development of proteomic technologies including the advancement of mass spectrometers with high sensitivity and speed has greatly advanced the discovery of potential biomarkers. One of the bottlenecks lies in the development of well-established verification assays to screen the biomarker candidates identified in the discovery stage. Recently, absolute quantitation using multiple-reaction monitoring mass spectrometry (MRM-MS) in combination with isotope-labeled internal standards has been extensively investigated as a tool for high-throughput protein biomarker verification. In this review, we describe and discuss recent developments and applications of MRM-MS methods for biomarker verification.
Copyright © 2011. Published by Elsevier B.V.

Mesh:

Substances:

Year:  2011        PMID: 21540133     DOI: 10.1016/j.jprot.2011.04.011

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  34 in total

1.  Carrying yourself: self antigen composition of the lymphatic fluid.

Authors:  Laura Santambrogio; Lawrence J Stern
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 2.  Current application of proteomics in biomarker discovery for inflammatory bowel disease.

Authors:  Patrick Py Chan; Valerie C Wasinger; Rupert W Leong
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 3.  Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Authors:  Eugene M Cilento; Lorrain Jin; Tessandra Stewart; Min Shi; Lifu Sheng; Jing Zhang
Journal:  J Neurochem       Date:  2019-01-31       Impact factor: 5.372

4.  Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.

Authors:  Anuli Christiana Uzozie; Nathalie Selevsek; Asa Wahlander; Paolo Nanni; Jonas Grossmann; Achim Weber; Federico Buffoli; Giancarlo Marra
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

Review 5.  Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

Authors:  Carol E Parker; Christoph H Borchers
Journal:  Mol Oncol       Date:  2014-03-20       Impact factor: 6.603

Review 6.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

7.  Ultrasensitive sample quantitation via selected reaction monitoring using CITP/CZE-ESI-triple quadrupole MS.

Authors:  Chenchen Wang; Cheng S Lee; Richard D Smith; Keqi Tang
Journal:  Anal Chem       Date:  2012-11-20       Impact factor: 6.986

8.  Glycocapture-assisted global quantitative proteomics (gagQP) reveals multiorgan responses in serum toxicoproteome.

Authors:  Bingyun Sun; Angelita G Utleg; Zhiyuan Hu; Shizhen Qin; Andrew Keller; Cynthia Lorang; Li Gray; Amy Brightman; Denis Lee; Vinita M Alexander; Jeffrey A Ranish; Robert L Moritz; Leroy Hood
Journal:  J Proteome Res       Date:  2013-04-11       Impact factor: 4.466

9.  Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury.

Authors:  Sakthivel Sadayappan
Journal:  Biomark Med       Date:  2012-02       Impact factor: 2.851

10.  Elastomeric negative acoustic contrast particles for affinity capture assays.

Authors:  Kevin W Cushing; Menake E Piyasena; Nick J Carroll; Gian C Maestas; Beth Ann López; Bruce S Edwards; Steven W Graves; Gabriel P López
Journal:  Anal Chem       Date:  2013-02-05       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.